Cargando…

Expression of DNA mismatch repair proteins in melanoma patients treated with immune checkpoint inhibitors

PURPOSE: To investigate the protein expression of DNA mismatch repair (MMR) proteins in patients with cutaneous melanoma (CM) under immune checkpoint inhibitor (ICI) therapy. METHODS: Immunohistochemistry was performed on tumor tissue for MMR proteins MLH1, MSH2, MSH6, and PMS2 in 50 metastatic CM p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gambichler, T., Finis, C., Abu Rached, N., Scheel, C. H., Becker, J. C., Lang, K., Käfferlein, H. U., Brüning, T., Abolmaali, N., Susok, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article – Clinical Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984342/ https://www.ncbi.nlm.nih.gov/pubmed/35419731 http://dx.doi.org/10.1007/s00432-022-04002-4

Ejemplares similares

Expression of Mismatch Repair Proteins in Merkel Cell Carcinoma
por: Gambichler, Thilo, et al.
Publicado: (2021)

Mismatch Repair Protein Expression and Microsatellite Instability in Cutaneous Squamous Cell Carcinoma
por: Gambichler, Thilo, et al.
Publicado: (2021)

Pan-immune-inflammation value independently predicts disease recurrence in patients with Merkel cell carcinoma
por: Gambichler, T., et al.
Publicado: (2022)

Protein expression of prognostic genes in primary melanoma and benign nevi
por: Gambichler, T., et al.
Publicado: (2021)

The pan-immune-inflammation value and systemic immune-inflammation index in advanced melanoma patients under immunotherapy
por: Susok, L., et al.
Publicado: (2022)

Prognostic Potential of the Baseline Pan-Immune-Inflammation Value and Neutrophil/Lymphocyte Ratio in Stage I to III Melanoma Patients
por: Gambichler, Thilo, et al.
Publicado: (2022)

Cutaneous findings following COVID‐19 vaccination: review of world literature and own experience
por: Gambichler, T., et al.
Publicado: (2021)

Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection
por: Gambichler, Thilo, et al.
Publicado: (2020)

Caucasians with acral lentiginous melanoma have the same outcome as patients with stage- and limb-matched superficial spreading melanoma
por: Susok, Laura, et al.
Publicado: (2021)

Model for End-Stage Liver Disease Correlates with Disease Relapse and Death of Patients with Merkel Cell Carcinoma
por: Gambichler, Thilo, et al.
Publicado: (2023)

Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade
por: Gambichler, Thilo, et al.
Publicado: (2017)

Multivariate analysis of prognostic factors in patients with nodular melanoma
por: Susok, L., et al.
Publicado: (2021)

The Antineoplastic Effect of Dimethyl Fumarate on Virus-Negative Merkel Cell Carcinoma Cell Lines: Preliminary Results
por: Gambichler, Thilo, et al.
Publicado: (2023)

Advances in Targeting Cutaneous Melanoma
por: Kasakovski, Dimitri, et al.
Publicado: (2021)

Evans’ syndrome following vaccination with ChAdOx1 nCoV-19 in a patient with new-onset localized scleroderma
por: Gambichler, Thilo, et al.
Publicado: (2022)

Antibody-Negative Paraneoplastic Autoimmune Multiorgan Syndrome (PAMS) in a Patient with Follicular Lymphoma Accompanied by an Excess of Peripheral Blood CD8+ Lymphocytes
por: Gambichler, Thilo, et al.
Publicado: (2022)

Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combination therapy
por: Gambichler, Thilo, et al.
Publicado: (2018)

On the use of immune checkpoint inhibitors in patients with viral infections including COVID-19
por: Gambichler, Thilo, et al.
Publicado: (2020)

Undifferentiated pleomorphic sarcoma of the breast with neoplastic fever: case report and genomic characterization
por: Gambichler, Thilo, et al.
Publicado: (2022)

POLE and Mismatch Repair Status, Checkpoint Proteins and Tumor-Infiltrating Lymphocytes in Combination, and Tumor Differentiation: Identify Endometrial Cancers for Immunotherapy
por: Dong, Dandan, et al.
Publicado: (2021)

PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors
por: Gabryś, H. S., et al.
Publicado: (2022)

Waiving Subsequent Complete Lymph Node Dissection in Melanoma Patients with Positive Sentinel Lymph Node Does Not Result in Worse Outcome on 20-Year Analysis
por: Susok, Laura, et al.
Publicado: (2021)

Primary Cutaneous CD30+ Anaplastic Large T Cell Lymphoma in a Patient Treated with Cyclosporine for Actinic Reticuloid
por: Gambichler, T., et al.
Publicado: (2020)

Phenotypic plasticity of malignant T cells in blood and skin of a Sézary syndrome patient revealed by single cell transcriptomics
por: Peiffer, Lukas, et al.
Publicado: (2023)

Prognostic Performance of Inflammatory Biomarkers Based on Complete Blood Counts in COVID-19 Patients
por: Gambichler, Thilo, et al.
Publicado: (2023)

Organoids and metastatic orthotopic mouse model for mismatch repair-deficient colorectal cancer
por: Song, Yurong, et al.
Publicado: (2023)

Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma
por: Ho, Joel, et al.
Publicado: (2022)

Biomarkers for Immune Checkpoint Inhibitors in Melanoma
por: Kitano, Shigehisa, et al.
Publicado: (2018)

Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Therapy
por: Burke, Aidan M., et al.
Publicado: (2022)

Loss of Cdx2 Expression in Primary Tumors and Lymph Node Metastases is Specific for Mismatch Repair-Deficiency in Colorectal Cancer
por: Dawson, Heather, et al.
Publicado: (2013)

A Rapid, Simple DNA Mismatch Repair Substrate Construction Method
por: Du, Weinan, et al.
Publicado: (2011)

Mismatch repair deficiency testing in Lynch syndrome-associated urothelial tumors
por: Rasmussen, Maria, et al.
Publicado: (2023)

Mismatch repair–deficient prostate cancer with parenchymal brain metastases treated with immune checkpoint blockade
por: Sena, Laura A., et al.
Publicado: (2021)

Biomarkers for Response of Melanoma Patients to Immune Checkpoint Inhibitors: A Systematic Review
por: Jessurun, Charissa A. C., et al.
Publicado: (2017)

Computed Tomography Features of Gastric Cancer Patients With DNA Mismatch Repair Deficiency
por: Cao, Qian, et al.
Publicado: (2021)

Expression of HER2 and Mismatch Repair Proteins in Surgically Resected Gallbladder Adenocarcinoma
por: Sung, You-Na, et al.
Publicado: (2021)

Robust Glycogene-Based Prognostic Signature for Proficient Mismatch Repair Colorectal Adenocarcinoma
por: Li, Yixi, et al.
Publicado: (2021)

Mismatch repair deficiency, chemotherapy and survival for resectable gastric cancer: an observational study from the German staR cohort and a meta-analysis
por: Stolze, T., et al.
Publicado: (2022)

Survival outcomes analysis according to mismatch repair status in locally advanced rectal cancer patients treated with neoadjuvant chemoradiotherapy
por: Chen, Lin, et al.
Publicado: (2022)

Clinical Characterization of Mismatch Repair Gene-Deficient Metastatic Castration-Resistant Prostate Cancer
por: Ye, Senlin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dqe58cod92kp40u8c63sj9p4v4